Peptidoglycan is an essential constituent of bacterial cell walls since it prevents cell swelling and lysis 53 by mechanically sustaining the osmotic pressure of the cytoplasm (1). This protective function depends 54 upon synthesis and maintenance during the entire cell cycle of the net-like peptidoglycan 55 macromolecule, which completely surrounds the bacterial cell. Peptidoglycan is made of glycan strands 56 cross-linked by short peptide stems. In most bacteria, the cross-linking step is performed by D,D-57 transpeptidases, which are the essential targets of β-lactam antibiotics and are often referred to as 58 penicillin-binding proteins (PBPs) (2). In mycobacteria (3, 4) and in Clostridium difficile (5, 6), the cross-59 links found are mainly (70% to 80%) formed by a second class of enzymes, the L,D-transpeptidases 60 (LDTs). Since LDTs are not inhibited by β-lactams belonging to the penam class, such as ampicillin, (7, 61 8), these enzymes are responsible for high-level resistance to these drugs in mutants of Enterococcus 62 faecium (9, 10) and Escherichia coli (11) selected in laboratory conditions. 63
Tryptophan fluorescence quenching in β-lactam-interacting proteins is modulated by
) (2). LDTs are also acylated by β-lactams although efficacious enzyme 81 inactivation and antibacterial activity occur only for a single class of β-lactams, the carbapenems, such 82 as imipenem (7, 8) . β-lactams of the cephem (cephalosporin) class, such as ceftriaxone, are only active 83 at high concentrations since acylation is slower and the resulting thioester bond is prone to hydrolysis 84 (7). The kinetic parameters are even less favorable for penams (ampicillin and penicillin) leading to 85 equilibrium between the acylated and unacylated (functional) forms, which accounts for the lack of 86 antibacterial activity (7). 87
Fluorescence kinetics revealed that the acylation reaction of LDTs by β-lactams of the 88 carbapenem class comprises two limiting steps ( Fig. 1A and B ). In the first step, nucleophilic attack of 89 the β-lactam carbonyl by the negatively charged sulfur atom of the catalytic Cys was thought to lead 90 to formation of a covalent sulfur-carbon bond and to the development of a negative charge on the 91 drug (21). Initially, this negative charge was proposed to be located on the β-lactam oxygen (21). This 92 hypothesis was based on analogies with PBPs, which contain an oxyanion hole for stabilization of the 93 negative charge developing on the β-lactam oxygen (17). However, hybrid potential simulation of the 94 acylation reaction indicated that the path to an oxyanion is energetically disfavored in the case of LDTs 95
and that an oxyanion could not correspond to a stabilized reaction intermediate (22) . Rather, hybrid 96 potential simulation indicated that the most energetically favored reaction path involves a concerted 97 mechanism leading to the concomitant formation of the thioester bond, rupture of C-N β-lactam bond, 98 and formation of an amine anion (22). In the second step, the final acylenzyme is formed by 99 protonation of the amine anion. The origin of this proton remains elusive (18, 22) . Formation of a non-100 covalent complex is not considered in this reaction scheme as the affinity of the Ldtfm for carbapenems 101 is very low, in the order of 60 to 80 mM (7). 102
Fluorescence kinetics proved useful to assess the efficacy of inactivation of LDTs from 103
Mycobacterium tuberculosis (23-25) and contributed to the choice of the drugs that were tested in a 104 phase II clinical trial (26). The assays were also useful in evaluating series of synthetic carbapenems 105 (27) and non-β-lactam LDT inhibitors (28). However, the basis for the variation in fluorescence intensity 106 detected during the two steps of the acylation reaction remained elusive. Initially, we developed 107 fluorescence kinetics since determination of the crystal structure of Ldtfm revealed a Trp residue at the 108 entrance of the catalytic cavity (15), which appeared ideally located for fluorescence quenching upon 109 drug binding due to changes in its environment (21). However, this naïve explanation was subsequently 110 found to be insufficient to account for the various behaviors observed for acylation of LDTs by 111 representatives of the β-lactam classes (7, (22) (23) (24) (25) Supplementary Fig. S2 ). None of the Trp residues was essential for the acylation of Ldtfm by imipenem 144 although important variations were observed in the k1 (formation of the amine anion) and k2 (acylation 145 step) parameters ( Fig. 2A and 2B , respectively). The Trp to Phe substitutions produced large variations 146 in the intrinsic fluorescence of the three forms of the enzyme (apo Ldtfm, amine anion, and acylenzyme; 147 accounted for by modification of the environment of any specific Trp residue, our next objective was 172 to investigate whether quenching could result from energy transfer from Trp residues to the Cys-β-173 lactam covalent adduct generated upon enzyme inactivation. To investigate this possibility, we first 174 examined acylation of Ldtfm by the chromogenic cephalosporin nitrocefin. Fluorescence kinetics with 175 this compound displayed a monophasic behavior with a large decrease (72%) in the fluorescence 176 intensity (Fig. 3A ). In the Ldtfm-nitrocefin acylenzyme, the negative charge developing on the β-lactam 177 nitrogen is stabilized by a mesomeric effect that prevents protonation of the amine (30). Thus, the 178 amine anion formed as an end product with nitrocefin ( Fig. 3A) or as an intermediate with imipenem 179 (Fig. 1 ) was associated with extensive fluorescence quenching. As found for nitrocefin, acylation of 180
Ldtfm by ceftriaxone led to a monophasic decrease in the fluorescence intensity (Fig. 3B) . Acylation of 181
Ldtfm by ceftriaxone involves a concerted mechanism leading to the elimination of the side chain and 182 formation of a conjugated imine (7). Fig. S5 ) was not associated with 200 any significant modification of the fluorescence intensity of the enzyme (Fig. 3D) . Protonation of the 201 amino sulfate nitrogen of avibactam in the avibactam-BlaC adduct was thus associated with limited 202 quenching as found for the protonation of the β-lactam nitrogen in the final Ldtfm-imipenem and BlaC-203 clavulanate adducts ( Fig. 1 and 3C (Fig. 3E ). The resulting acylenzyme contained an unprotonated β-lactam 209 nitrogen. In contrast, acylation of Ldtfm by faropenem, which resulted in the rupture of the C 5 -C 6 bond 210 and the loss of a large portion of the drug including the β-lactam nitrogen (24), was associated with a 211 moderate decrease in the fluorescence intensity (17%) (Fig. 3F) . 212 213
Acylation of BlaC by the meropenem carbapenem. Although BlaC displays moderate carbapenemase 214 activity, previous studies have shown that a BlaC-meropenem adduct is the predominant enzyme form 215 upon incubation of the enzyme with low drug concentrations (34, 35). As expected, the control 216 experiment depicted in Supplementary Fig. S6 shows that the concentration of meropenem remains 217 saturating for at least 80 min during hydrolysis of meropenem (40 -200 µM) by BlaC (10 µM). 218
Fluorescence kinetics at a shorter time scale (6 min) showed a transitory decrease in fluorescence 219 intensity (40%) (Fig. 3G ). This observation suggests that formation of an amine anion initially leads to 220 an important fluorescence quenching. Then, fluorescence returned to the initial level suggesting that 221 protonation of the amine anion fully suppressed quenching. Thus, formation of an amine anion 222 following nucleophilic attack of the carbonyl carbon of carbapenems by Ldtfm (Fig. 1) In contrast, we show here that the variations in fluorescence during acylation of LDTs by β-lactam 239 antibiotics require at least one Trp residue but that the position of this residue is not determinant. This 240 was established by deleting Trp residues from Ldtfm in various combinations ( Fig. 1 and 2) , by 241 introducing a single Trp residue in an ectopic position of Ldtfm (Fig. S4) , and by showing that large 242 variations in fluorescence intensity occur in distantly related LDTs and unrelated β-lactamases that do 243 not share any conserved Trp residue (Fig. S3 ). Since fluorescence quenching was not mainly due to 244 changes in the environment of Trp residues, we investigated the possibility that the nucleophilic attack 245 of the β-lactam ring could itself generate a fluorescence quencher. If this is the case, the fluorescence 246 profile should depend upon the structural features of the drug bound to the active-site residue. 247 Accordingly, extensive quenching was not mainly determined by the size of the side chains of β-lactams 248 or by the nature of the enzyme nucleophile (Cys versus Ser in Ldtfm and BlaC, respectively) (Fig .3) Spectrofluorimetry. Fluorescence kinetics were studied in 100 mM sodium phosphate (pH 6.0) at 20°C 277 by using a stopped-flow apparatus (RX-2000, Applied Biophysics) coupled to a spectrofluorimeter (Cary 278 Eclipse; Varian). Excitation was performed at 224 nm with a 5 nm slit and a 2 mm optical path. 279
Fluorescence emission was determined at 335 nm with a 5 nm slit and a 10 mm optical path. 280
Fluorescence data were collected exactly in the same conditions for comparison of the relative 281 fluorescence of wild-type Ldtfm and derivatives with Trp to Phe and His to Ala substitutions. These 282 conditions included the photomultiplier voltage, which was set to 600 V. 283 284
Mass spectrometry. Formation of the proposed Ldtfm-β-lactam and BlaC-β-lactam adducts in the 285 conditions described in the text was systematically checked by mass spectrometry (data not shown). 286
Enzymes and β-lactams were incubated for appropriate time periods at 20°C. Five μl of acetonitrile 287 and 1 μl of 1% formic acid were extemporaneously added. Injection in the mass spectrometer (Qstar 288 Pulsar I; Applied Biosystem) was performed at a flow rate of 0.05 ml/min (acetonitrile, 50%, water, 289 49.5%, and formic acid, 0.5%; per volume). Spectra were acquired in the positive mode, as previously 290 described (8). Detailed analyses of the mass spectra of the β-lactam adducts considered in the current 291 study have been previously published (7, 8, 24, 29, 40 
